Genetic and Phenotypic Characteristics of Mitral Valve Prolapse (MVP)
Study Overview
Status
Status
Conditions
Conditions
Detailed Description
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Thierry Le Tourneau, PU-PH
- Phone Number: 0617908670
- Email: thletourneau@yahoo.fr
Study Locations
-
-
-
Brest, France, 29200
- Not yet recruiting
- Brest University Hospital
-
Contact:
- Jacques Mansourati, PU-PH
- Phone Number: 02 98 34 73 91
- Email: jacques.mansourati@chu-brest.fr
-
Sub-Investigator:
- Yves Etienne, PH
-
Sub-Investigator:
- Yannick Jobic, PH
-
Nantes, France, 44093
- Recruiting
- Nantes university hospital
-
Contact:
- Thierry Le Tourneau, PU-PH
- Phone Number: 0617908670
- Email: thletourneau@yahoo.fr
-
Principal Investigator:
- Thierry Le Tourneau, PU-PH
-
Rennes, France, 35033
- Recruiting
- Rennes University Hospital
-
Contact:
- Erwan Donal, PU-PH
- Phone Number: 02 99 28 25 27
- Email: erwan.donal@chu-rennes.fr
-
Principal Investigator:
- Erwan Donal, PU-PH
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients of any age
- with typical mitral valve prolapse
- relatives examined during familial screening
Exclusion Criteria:
- Refusal of the patient
Study Plan
How is the study designed?
Design Details
- Observational Models: Family-Based
- Time Perspectives: Prospective
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
|---|
|
Patients with MVP
The patients concerned are patients with known or recently discovered Barlow-type mitral prolapse, whatever the degree of severity.
|
|
Normal relatives
Related healthy patients, for an average of 6 individuals per family
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
MVP defined by a superior displacement of at least 2 mm
Time Frame: At Day 0
|
MVP defined by a superior displacement of at least 2 mm
|
At Day 0
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Comprehensive mitral valve apparatus characterization per size of items (leaflets, chordae, annulus)
Time Frame: At Day 0
|
Leaflets length ; Chordae length ; Annulus diameter
|
At Day 0
|
|
Comprehensive mitral valve apparatus characterization per other items (papillary muscle, ventricles)
Time Frame: At Day 0
|
Papillary muscles aspect ; Right Ventricle function ; Left Ventricle Ejection Fraction
|
At Day 0
|
|
Comprehensive mitral valve apparatus characterization per size of items (ventricle and atrium sizes)
Time Frame: At Day 0
|
Left ventricle and atrium sizes ; right ventricle size ; right Atrium size
|
At Day 0
|
|
Comprehensive mitral valve apparatus characterization per size of items
Time Frame: At Day 0
|
Leaflets thickness
|
At Day 0
|
Other Outcome Measures
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Incidence of cardiac or clinical defects associated with MVP
Time Frame: At Day 0 Follow-up will be carried out at 5 and 10 years
|
Atrial septal defect, ventricular septal defect, patent ductus arteriosus, tricuspid or aortic valve abnormalities (prolapse, bicuspid AV…), coarctation, ascending aorta aneurysm
|
At Day 0 Follow-up will be carried out at 5 and 10 years
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Vincent Probst, PU-PH, Nantes university hospital
- Principal Investigator: Hervé Le Marec, PU-PH, Nantes university hospital
- Principal Investigator: Jean-Jacques Schott, DR, Institut National de la Santé Et de la Recherche Médicale, France
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Anticipated)
Primary Completion
Study Completion (Anticipated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- RC12_0143
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.